SI1840125T1 - Intermediati za pripravo dioksan-2-alkil karbamatov - Google Patents

Intermediati za pripravo dioksan-2-alkil karbamatov

Info

Publication number: SI1840125T1
Authority: SI; Slovenia
Prior art keywords: intermediates; dioxane; preparation; alkyl carbamates; carbamates
Prior art date: 2002-08-29

Application number

SI200331666T

Other languages

English (en)

Inventor

Ahmed Abouabdellah

Michele Bas

Gihad Dargazanli

Christian Hoornaert

Adrien Tak Li

Florence Medaisko

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-29

Filing date

2003-08-27

Publication date

2009-12-31

2003-08-27 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2009-12-31 Publication of SI1840125T1 publication Critical patent/SI1840125T1/sl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Physical Education & Sports Medicine (AREA)
Immunology (AREA)
Virology (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Ophthalmology & Optometry (AREA)
Molecular Biology (AREA)
Otolaryngology (AREA)
Psychology (AREA)
Dermatology (AREA)
Hospice & Palliative Care (AREA)
Tropical Medicine & Parasitology (AREA)
Anesthesiology (AREA)
Nutrition Science (AREA)

SI200331666T 2002-08-29 2003-08-27 Intermediati za pripravo dioksan-2-alkil karbamatov SI1840125T1 (sl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0210707A FR2843964B1 (fr)	2002-08-29	2002-08-29	Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
EP07013954A EP1840125B1 (fr)	2002-08-29	2003-08-27	Intermédiaires pour la production de dioxane-2-alkylcarbamates

Publications (1)

Publication Number	Publication Date
SI1840125T1 true SI1840125T1 (sl)	2009-12-31

Family

ID=31502974

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SI200331666T SI1840125T1 (sl)	2002-08-29	2003-08-27	Intermediati za pripravo dioksan-2-alkil karbamatov
SI200331438T SI1537096T1 (sl)	2002-08-29	2003-08-27	Dioksan-2-alkilkarbamatni derivati, njihova priprava in njihova terapevtska uporaba

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SI200331438T SI1537096T1 (sl)	2002-08-29	2003-08-27	Dioksan-2-alkilkarbamatni derivati, njihova priprava in njihova terapevtska uporaba

Country Status (34)

Country	Link
US (4)	US7119116B2 (sl)
EP (2)	EP1537096B1 (sl)
JP (2)	JP4585854B2 (sl)
KR (2)	KR101051192B1 (sl)
CN (3)	CN101906071A (sl)
AR (1)	AR041053A1 (sl)
AT (2)	ATE409184T1 (sl)
AU (1)	AU2003274292B2 (sl)
BR (1)	BR0313846A (sl)
CA (2)	CA2700319C (sl)
CO (1)	CO5700820A2 (sl)
CY (2)	CY1108792T1 (sl)
DE (2)	DE60328138D1 (sl)
DK (2)	DK1840125T3 (sl)
EA (1)	EA008218B1 (sl)
ES (2)	ES2329181T3 (sl)
FR (1)	FR2843964B1 (sl)
HR (2)	HRP20090270B1 (sl)
IL (1)	IL166882A (sl)
IS (1)	IS2733B (sl)
MA (1)	MA27390A1 (sl)
ME (2)	MEP24208A (sl)
MX (1)	MXPA05002319A (sl)
NO (2)	NO331165B1 (sl)
NZ (1)	NZ538404A (sl)
PL (1)	PL209339B1 (sl)
PT (2)	PT1840125E (sl)
RS (2)	RS51085B (sl)
SI (2)	SI1840125T1 (sl)
TN (1)	TNSN05057A1 (sl)
TW (2)	TWI294878B (sl)
UA (1)	UA82847C2 (sl)
WO (1)	WO2004020430A2 (sl)
ZA (1)	ZA200501537B (sl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2843964B1 (fr) *	2002-08-29	2004-10-01	Sanofi Synthelabo	Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
JP4515911B2 (ja) *	2002-10-07	2010-08-04	ザリージェンツオブザユニバーシティオブカリフォルニア	アナンダミド加水分解の遮断による不安の調節
FR2854633B1 (fr) *	2003-05-07	2005-06-24	Sanofi Synthelabo	Derives de piperidinyl-et piperazinyl-alkylcarbamates, leur preparation et leur application en therapeutique
FR2865205B1 (fr) *	2004-01-16	2006-02-24	Sanofi Synthelabo	Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique
FR2866886B1 (fr) *	2004-02-26	2007-08-31	Sanofi Synthelabo	Derives d'aryl-et d'heteroaryl-akylcarbamates, leur preparation et leur application en therapeutique
FR2866884B1 (fr) *	2004-02-26	2007-08-31	Sanofi Synthelabo	Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application en therapeutique
FR2866885B1 (fr)	2004-02-26	2007-08-31	Sanofi Synthelabo	Derives de piperidinylalkylcarbamates, leur prepation et leur application en therapeutique
FR2866888B1 (fr) *	2004-02-26	2006-05-05	Sanofi Synthelabo	Derives de alkylpiperazine- et alkylhomopiperazine- carboxylates, leur preparation et leur application en therapeutique
US7269708B2 (en) *	2004-04-20	2007-09-11	Rambus Inc.	Memory controller for non-homogenous memory system
US20080103209A1 (en) *	2004-04-23	2008-05-01	The Regents Of The University Of California	Compounds And Methods For Treating Non-Inflammatory Pain Using Ppar Alpha Agonists
DE102004039326A1 (de) *	2004-08-12	2006-02-16	Abbott Gmbh & Co. Kg	Neue medizinische Verwendungen und Verfahren
EP1849773B1 (en)	2005-02-17	2013-10-16	Astellas Pharma Inc.	Piperazine derivatives for the treatment of urinary incontinence and pain
FR2885364B1 (fr) *	2005-05-03	2007-06-29	Sanofi Aventis Sa	Derives d'alkyl-, alkenyl-et alkynylcarbamates, leur preparation et leur application en therapeutique
CA2661085A1 (en) *	2006-08-18	2008-02-21	N.V. Organon	Combination faah inhibitor and analgesic, anti-inflammatory or anti-pyretic agent
US20080089845A1 (en) *	2006-09-07	2008-04-17	N.V. Organon	Methods for determining effective doses of fatty acid amide hydrolase inhibitors in vivo
US20090099240A1 (en) *	2006-10-02	2009-04-16	N.V. Organon	Methods for treating energy metabolism disorders by inhibiting fatty acid amide hydrolase activity
US20080119549A1 (en) *	2006-11-20	2008-05-22	N.V. Organon	Metabolically-stabilized inhibitors of fatty acid amide hydrolase
US8207226B1 (en)	2008-06-03	2012-06-26	Alcon Research, Ltd.	Use of FAAH antagonists for treating dry eye and ocular pain
FR2941696B1 (fr) *	2009-02-05	2011-04-15	Sanofi Aventis	Derives d'azaspiranyl-alkylcarbamates d'heterocycles a 5 chainons, leur preparation et leur application en therapeutique
TW201044234A (en) *	2009-06-08	2010-12-16	Chunghwa Picture Tubes Ltd	Method of scanning touch panel
EP2476682B1 (en)	2009-09-09	2017-04-26	Sumitomo Dainippon Pharma Co., Ltd.	8-oxodihydropurine derivative
US8274566B2 (en) *	2009-10-09	2012-09-25	John Mezzalingua Associates, Inc.	Modulation analyzer and level measurement device
EP2545914A1 (en)	2011-07-11	2013-01-16	Sanofi	2-amino-2-oxoethyl trans-3-[5-(6-methoxy-naphtalen-1-yl)-1,3-dioxan-2-yl]propyl-carbamate for use in the treatment of persistent cancer pain
EP2545915A1 (en)	2011-07-11	2013-01-16	Sanofi	2-amino-2-oxoethyl trans-3-[5-(6-methoxy-naphtalen-1-yl)-1,3-dioxan-2-yl]propyl-carbamate for use in the treatment of persistent cancer pain
AU2013207252B2 (en) *	2012-01-06	2016-06-09	H.Lundbeck A/S	Carbamate compounds and pharmaceutical compositions thereof
CN114835726B (zh) *	2022-03-24	2024-01-26	上海诺精生物科技有限公司	一类抑制肿瘤细胞干性的化合物及用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69103968T2 (de) *	1990-06-15	1995-03-23	Synthelabo	2-(Aminoalkyl)-5-(arylalkyl)1,3-dioxanderivate, ihre Herstellung und ihre Anwendung in der Therapeutik.
US5173506A (en) *	1990-08-16	1992-12-22	Schering Corporation	N-(mercaptoalkyl)ureas and carbamates
FR2742152B1 (fr) *	1995-12-06	1998-01-16	Synthelabo	Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique
AT403579B (de) *	1995-12-07	1998-03-25	Agrolinz Melamin Gmbh	Verfahren zur herstellung von hochreinem melamin
PL337234A1 (en) *	1997-06-05	2000-08-14	Sanofi Synthelabo	Derivatives of 5-naphtalen-1-yl-1,3-dioxane, their production and therapeutic application
ID28658A (id) *	1998-04-16	2001-06-21	Texas Biotechnology Corp	Senyawa yang menghambat pengikatan integrin pada reseptornya
FR2816938B1 (fr)	2000-11-22	2003-01-03	Sanofi Synthelabo	Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant
FR2843964B1 (fr) *	2002-08-29	2004-10-01	Sanofi Synthelabo	Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique

2002
- 2002-08-29 FR FR0210707A patent/FR2843964B1/fr not_active Expired - Fee Related
2003
- 2003-08-26 AR ARP030103063A patent/AR041053A1/es active IP Right Grant
- 2003-08-27 RS YUP-2005/0182A patent/RS51085B/sr unknown
- 2003-08-27 SI SI200331666T patent/SI1840125T1/sl unknown
- 2003-08-27 MX MXPA05002319A patent/MXPA05002319A/es active IP Right Grant
- 2003-08-27 AT AT03758282T patent/ATE409184T1/de active
- 2003-08-27 DK DK07013954T patent/DK1840125T3/da active
- 2003-08-27 CN CN2010101829555A patent/CN101906071A/zh active Pending
- 2003-08-27 DE DE60328138T patent/DE60328138D1/de not_active Expired - Lifetime
- 2003-08-27 RS RSP-2010/0169A patent/RS20100169A/sr unknown
- 2003-08-27 EP EP03758282A patent/EP1537096B1/fr not_active Expired - Lifetime
- 2003-08-27 ZA ZA200501537A patent/ZA200501537B/en unknown
- 2003-08-27 PT PT07013954T patent/PT1840125E/pt unknown
- 2003-08-27 HR HRP20090270AA patent/HRP20090270B1/hr not_active IP Right Cessation
- 2003-08-27 CA CA2700319A patent/CA2700319C/en not_active Expired - Fee Related
- 2003-08-27 HR HRP20050190AA patent/HRP20050190B1/hr not_active IP Right Cessation
- 2003-08-27 CA CA2496040A patent/CA2496040C/en not_active Expired - Fee Related
- 2003-08-27 KR KR1020057003244A patent/KR101051192B1/ko not_active Expired - Fee Related
- 2003-08-27 EA EA200500268A patent/EA008218B1/ru not_active IP Right Cessation
- 2003-08-27 DK DK03758282T patent/DK1537096T3/da active
- 2003-08-27 DE DE60323754T patent/DE60323754D1/de not_active Expired - Lifetime
- 2003-08-27 WO PCT/FR2003/002590 patent/WO2004020430A2/fr not_active Ceased
- 2003-08-27 ME MEP-242/08A patent/MEP24208A/xx unknown
- 2003-08-27 SI SI200331438T patent/SI1537096T1/sl unknown
- 2003-08-27 BR BR0313846-1A patent/BR0313846A/pt not_active Application Discontinuation
- 2003-08-27 ES ES07013954T patent/ES2329181T3/es not_active Expired - Lifetime
- 2003-08-27 AT AT07013954T patent/ATE434598T1/de active
- 2003-08-27 KR KR1020107028059A patent/KR101139160B1/ko not_active Expired - Fee Related
- 2003-08-27 PT PT03758282T patent/PT1537096E/pt unknown
- 2003-08-27 AU AU2003274292A patent/AU2003274292B2/en not_active Ceased
- 2003-08-27 NZ NZ538404A patent/NZ538404A/en not_active IP Right Cessation
- 2003-08-27 JP JP2004532233A patent/JP4585854B2/ja not_active Expired - Fee Related
- 2003-08-27 CN CNB038241056A patent/CN100491368C/zh not_active Expired - Fee Related
- 2003-08-27 ES ES03758282T patent/ES2312808T3/es not_active Expired - Lifetime
- 2003-08-27 EP EP07013954A patent/EP1840125B1/fr not_active Expired - Lifetime
- 2003-08-27 CN CN200810186321XA patent/CN101445504B/zh not_active Expired - Fee Related
- 2003-08-27 UA UAA200501766A patent/UA82847C2/uk unknown
- 2003-08-27 PL PL375753A patent/PL209339B1/pl unknown
- 2003-08-28 TW TW092123746A patent/TWI294878B/zh not_active IP Right Cessation
- 2003-08-28 TW TW096123915A patent/TWI337606B/zh not_active IP Right Cessation
2004
- 2004-03-11 ME MEP-2008-242A patent/ME00108B/me unknown
2005
- 2005-02-14 IL IL166882A patent/IL166882A/en not_active IP Right Cessation
- 2005-02-17 IS IS7699A patent/IS2733B/is unknown
- 2005-02-22 US US11/062,541 patent/US7119116B2/en not_active Expired - Lifetime
- 2005-02-24 CO CO05017682A patent/CO5700820A2/es active IP Right Grant
- 2005-02-25 TN TNP2005000057A patent/TNSN05057A1/fr unknown
- 2005-02-25 NO NO20051051A patent/NO331165B1/no not_active IP Right Cessation
- 2005-02-28 MA MA28125A patent/MA27390A1/fr unknown
2006
- 2006-06-28 US US11/426,964 patent/US20060247290A1/en not_active Abandoned
2008
- 2008-12-12 CY CY20081101445T patent/CY1108792T1/el unknown
2009
- 2009-07-28 US US12/510,326 patent/US7777057B2/en not_active Expired - Fee Related
- 2009-09-24 CY CY20091100995T patent/CY1109441T1/el unknown
2010
- 2010-06-18 JP JP2010139427A patent/JP5244863B2/ja not_active Expired - Fee Related
- 2010-07-12 US US12/834,268 patent/US8119687B2/en not_active Expired - Fee Related
2011
- 2011-04-15 NO NO20110598A patent/NO335866B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU2003274292A1 (en)	2004-03-19
PL375753A1 (en)	2005-12-12
WO2004020430A2 (fr)	2004-03-11
EA008218B1 (ru)	2007-04-27
IS7699A (is)	2005-02-17
CN100491368C (zh)	2009-05-27
ATE409184T1 (de)	2008-10-15
KR20050059108A (ko)	2005-06-17
KR101051192B1 (ko)	2011-07-21
HRP20090270B1 (hr)	2015-12-04
CN1777595A (zh)	2006-05-24
HRP20050190B1 (hr)	2013-10-25
CA2700319C (en)	2012-07-17
CA2496040A1 (en)	2004-03-11
EA200500268A1 (ru)	2005-10-27
EP1537096A2 (fr)	2005-06-08
TNSN05057A1 (fr)	2007-05-14
TW200422294A (en)	2004-11-01
ATE434598T1 (de)	2009-07-15
ME00108B (me)	2010-10-10
NO20110598L (no)	2005-03-29
ES2329181T3 (es)	2009-11-23
HK1074445A1 (zh)	2005-11-11
MXPA05002319A (es)	2005-06-08
UA82847C2 (en)	2008-05-26
US20100280076A1 (en)	2010-11-04
HRP20090270A2 (hr)	2009-09-30
DE60323754D1 (de)	2008-11-06
US20060247290A1 (en)	2006-11-02
CY1109441T1 (el)	2014-08-13
EP1840125A3 (fr)	2007-11-21
JP2010248218A (ja)	2010-11-04
TW200738667A (en)	2007-10-16
US8119687B2 (en)	2012-02-21
KR20100134807A (ko)	2010-12-23
CN101906071A (zh)	2010-12-08
DK1840125T3 (da)	2009-11-09
SI1537096T1 (sl)	2009-02-28
US20090286868A1 (en)	2009-11-19
JP5244863B2 (ja)	2013-07-24
CY1108792T1 (el)	2014-04-09
FR2843964A1 (fr)	2004-03-05
HK1108157A1 (zh)	2008-05-02
ZA200501537B (en)	2006-10-25
JP4585854B2 (ja)	2010-11-24
IS2733B (is)	2011-04-15
US7777057B2 (en)	2010-08-17
CA2700319A1 (en)	2004-03-11
WO2004020430A3 (fr)	2004-04-22
EP1840125A2 (fr)	2007-10-03
CA2496040C (en)	2011-04-05
KR101139160B1 (ko)	2012-04-26
HRP20050190A2 (en)	2005-10-31
PT1840125E (pt)	2009-09-29
NZ538404A (en)	2007-07-27
AU2003274292B2 (en)	2009-05-28
NO335866B1 (no)	2015-03-09
IL166882A (en)	2010-12-30
US7119116B2 (en)	2006-10-10
RS51085B (sr)	2010-10-31
CO5700820A2 (es)	2006-11-30
AR041053A1 (es)	2005-04-27
ES2312808T3 (es)	2009-03-01
DK1537096T3 (da)	2009-02-02
TWI294878B (en)	2008-03-21
MA27390A1 (fr)	2005-06-01
NO331165B1 (no)	2011-10-24
MEP24208A (en)	2010-06-10
CN101445504A (zh)	2009-06-03
PL209339B1 (pl)	2011-08-31
RS20050182A (sr)	2007-09-21
PT1537096E (pt)	2008-12-11
NO20051051L (no)	2005-03-29
EP1537096B1 (fr)	2008-09-24
TWI337606B (en)	2011-02-21
JP2005539045A (ja)	2005-12-22
US20050182130A1 (en)	2005-08-18
CN101445504B (zh)	2010-12-29
DE60328138D1 (de)	2009-08-06
FR2843964B1 (fr)	2004-10-01
EP1840125B1 (fr)	2009-06-24
RS20100169A (sr)	2011-04-30
BR0313846A (pt)	2005-09-27

Publication	Publication Date	Title
PT1840125E (pt)	2009-09-29	Intermediários para a produção de dioxano-2-alquilcarbamatos
EG23458A (en)	2005-10-02	Set of elements for assemlying structures
HUP0304041A3 (en)	2005-08-29	Compounds useful as intermediates
AU2003219960A8 (en)	2003-09-16	Child-seat liners
IL223579A0 (en)	2013-02-03	Synthesis of amines and intermediates for the synthesis thereof
AU2003253188A8 (en)	2004-03-19	Novel processes and intermediates for preparing triazolo-pyridines
AU2003242614A8 (en)	2003-12-19	Method for the preparation of halogenated benzonitriles
PL371583A1 (en)	2005-06-27	Process for the preparation of 7alpha-methylsteroids
AU2003298725A8 (en)	2004-06-23	Preparation of metallotexaphyrins
SG111997A1 (en)	2005-06-29	Improved process for the preparation of polyalkylphenoxyaminoalkanes
SI1480949T1 (sl)	2015-09-30	Priprava prostamidov
IL164788A0 (en)	2005-12-18	Process for the preparation of 3-isochromanone
IL201472A0 (en)	2011-07-31	Intermediates for the preparation of dioxane-2-alkyl carbamates
PL1622926T3 (pl)	2009-12-31	Nowy sposób i produkty pośrednie wytwarzania związków 19-norsteroidów fluorowcowanych w pozycji 17
AU2003300867A8 (en)	2004-07-29	Uses of the snorf207 receptor
GB2393207B (en)	2006-04-12	Means of assembly
GB2385868B (en)	2005-12-14	Ring beams
AU2003226717A8 (en)	2003-10-08	Intermediates for the synthesis of discodermolide and related analogues and methods for their preparation
IL165356A0 (en)	2006-01-15	Preparation of 4-haloalkylkylnicotinamides
TW582544U (en)	2004-04-01	The improvement of the gradienter structure
IL163778A0 (en)	2005-12-18	Processes for the synthesis of chloroadenosine andmethylthioadenosine
IL163593A0 (en)	2005-12-18	Preparation of paroxetine involving novel intermediates
TW533774U (en)	2003-05-21	Structure improvement of flyswatter
SI1537210T1 (sl)	2006-08-31	Lazna oligonukleotidna inhibicija ekspresije CD40
TW543789U (en)	2003-07-21	Improved structure of projector